“Most favored nation” pricing model for certain drugs
According to a recent poll, three in four adults in the United States say the cost of medications is unaffordable.
Read More
Part D/Prescription Drugs
FDA ends advance notice for foreign drugmaker inspections: 5 notes
(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is ramping up oversight of foreign manufacturing sites by expanding its
Read MoreShould CMS monitor biosimilar coverage on formularies?
The U.S. Department of Health and Human Services Office of Inspector General (OIG) released a study that found many Medicare
Read MorePBMs and pharmacy closures
Those independent pharmacies, excluded from Medicare Part D networks, were more likely to close. A new research study conducted by
Read More6 drugs in shortage
(By: Alexandra Murphy for Becker’s Hospital Review) Here are six new drug shortages and discontinuations, according to drug supply databases
Read MoreTrump seeks to lower drugmakers’ Medicaid prices: 5 notes
(By: Alexandra Murphy for Becker’s Hospital Review) President Donald Trump is targeting the pharmaceutical industry as a way to help
Read MoreFDA probes compounding pharmacies over quality concerns
(By: Paige Twenter for Becker’s Hospital Review) The FDA plans to gather information from 250 compounding outsourcing pharmacies amid safety and
Read MoreMedicare Part D coverage of GLP-1s could raise costs by $48B
(By: Alexandra Murphy for Becker’s Hospital Review) Medicare coverage of obesity medications could drive a substantial rise in healthcare spending,
Read MoreStand-Alone Drug Plans Cover a Larger Share of Medicare Part D Enrollees Living in the Most Rural Areas Than Medicare Advantage Plans
(By Juliette Cubanski, Tricia Neuman, and Anthony Damico for The Kaiser Family Foundation Published: Apr 23, 2025) The growing role
Read MoreAttorneys general to Congress: Ban PBMs from owning pharmacies
By: Alexandra Murphy for Becker’s Hospital Review) A coalition of 39 state attorneys general called on Congress to pass legislation
Read More